pharmacie et médicaments – Nouveaux traitements du myélome multiple

This written question concerns the availability of new treatments for multiple myeloma, a type of blood cancer. It seeks information on how these advancements will be made accessible to patients. The question is directed towards the government, aiming to understand the policy and regulatory steps being taken to ensure timely access to innovative therapies for those affected by this disease.